Faridar, A., Gamez, N., Li, D., Wang, Y., Boradia, R., Thome, A. D., . . . Appel, S. H. (2025). Low-dose interleukin-2 in patients with mild to moderate Alzheimer's disease: A randomized clinical trial. Alzheimer's Research & Therapy, 17(1), 1. https://doi.org/10.1186/s13195-025-01791-x
Chicago Style (17th ed.) CitationFaridar, Alireza, et al. "Low-dose Interleukin-2 in Patients with Mild to Moderate Alzheimer's Disease: A Randomized Clinical Trial." Alzheimer's Research & Therapy 17, no. 1 (2025): 1. https://doi.org/10.1186/s13195-025-01791-x.
MLA (9th ed.) CitationFaridar, Alireza, et al. "Low-dose Interleukin-2 in Patients with Mild to Moderate Alzheimer's Disease: A Randomized Clinical Trial." Alzheimer's Research & Therapy, vol. 17, no. 1, 2025, p. 1, https://doi.org/10.1186/s13195-025-01791-x.